Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
| Brand name | FEBUXOSTAT |
| Generic name | FEBUXOSTAT |
| Active ingredient(s) | FEBUXOSTAT |
| Distributed by / for | Northstar Rx LLC., Memphis, TN 38141 |
| NDC | 16714-060-01 |
| Full product label | Febuxostat Tablets 80mg, RX Only, 30 Tablets per bottle, NorthStarx, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Industries Limited Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India, NDC 16714-060-01. |
| Recalling firm | SUN PHARMACEUTICAL INDUSTRIES INC |
| Distribution | Nationwide |
| Quantity | 7,488 bottles |
| Recall initiated | 2024-03-04 |
| Report date | 2024-03-20 |
| Recall completed | — |
| Recall number | D-0369-2024 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗